Skip to main content

Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics

PR Newswire - Tue Jul 11, 2023

Signs new $25 million credit agreement and extension of existing secured convertible credit agreement

Appoints world‐renowned healthcare leader Dr. Deborah L. Birx as Chief Executive Officer

Read more at prnewswire.com
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.